Developing a cataract doesn’t mean a permanent loss of vision quality, or having to give up the things you love. Typically done on an outpatient basis, the natural lens is removed and replaced with what is called an intraocular lens (IOL). The procedure is highly successful and most people regain very good vision.
Bausch + Lomb manufactures a full range of innovative products that empower ophthalmic surgeons to provide superior outcomes to their patients.
Bausch + Lomb introduced micro incision cataract surgery (MICS) to the market with its 1.8 mm MICS Phacoemulsification (cataract removal using ultrasound). The advent of MICS Phaco means that surgeons can benefit from Bausch + Lomb's clinical combination: phacoemulsification through a 1.8 mm incision and IOL technology, including a range of Standard IOLs such as the enVista monofocal, the Akreos MICS and AO lenses, and Specialty IOLs such as the Crystalens accommodating and enVista Toric lenses, that can be implanted through an enlarged incision.
Bausch + Lomb has redefined state of the art phacoemulsification with its 1.8 mm microincision cataract surgery (MICS) solution, delivering Every Essential Element and making surgery through a 1.8 mm incision a reality. Learn more about our advancing technnologies.
Every surgeon has a style with varying needs to protect, maintain and manoeuvre.
Our range of viscoelastics gives each surgeon the ability to choose the properties that
are right for each phase of the procedure.